ICN Biomedicals Inc.: The Costa Mesa biotech...
ICN Biomedicals Inc.: The Costa Mesa biotech research company, of which ICN Pharmaceuticals Inc. owns 69%, reported profit of $536,000, or 6 cents a share for the second quarter, down from the profit of $3.3 million, or 15 cents a share, reported during the second quarter of 1993. Second-quarter sales were $15.2 million, down from $15.4 million million during the same quarter last year. The company did not release six-month results.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
